Translating Advanced Cancer Research into Personalized, Passionate Treatment.
John Wayne Cancer Institute at Providence Saint John’s Health Center is a cancer research institute dedicated to the understanding, diagnosis, and innovative treatment of cancer in order to eliminate patient suffering and prolong survival.Read More
Clinical trials have always been an important part of John Wayne Cancer Institute. Our institute led the trials that established sentinel lymph node biopsy as the standard of care for melanoma and breast care and pioneered immunotherapy as treatment for melanoma. Today, our patients continue to have access to the latest treatments and trials. We are at the forefront of studying the biology of cancer as well as expanding treatment for those suffering world-wide.Learn More
Complex Surgical Oncology Fellowship
With a longstanding history of excellence in multidisciplinary cancer care and education, the John Wayne Cancer Institute continues to be a leader in training the next generation of leaders in the field of surgical oncology.Learn more about this fellowship
Urologic Oncology Fellowship
The JWCI provides world class, multidisciplinary training in genitourinary malignancies and urologic oncology research with innovative and cutting edge technology.Learn more about this fellowship
This training program focuses on endonasal endoscopic and keyhole surgical approaches, neuro-endoscopy, pituitary tumor management and multimodality neuro-oncology treatments.Learn more about this fellowship
Postdoctoral Lab-Based Translational Molecular Medicine Fellowship
As pioneers in translational studies on “liquid biopsies” involving circulating tumor cells in multiple types of solid tumors, the fellowship program also consists of studying epigenetic mechanisms regulating solid tumor as well as pharmacogenomics and immunogenomic based prediction of response to therapy.Learn more about this fellowship
Latest News & Events
Lunch & Learn: Frankly Speaking About Cancer – Bone Health
Join Frederick Singer, M.D., Director of the Endocrine & Bone Disease Program, on October 26, 2018 to learn how to best manage your bone health while undergoing treatment for cancer.
Scientific Presentation: Utility of Genetic & Epigenetic Blood Cell-Free DNA (cfDNA) Biomarkers in Management of Melanoma Patients with Regional Lymph Node Metastasis
Join Dr. Dave Hoon, Board Member of ISNS and Professor & Director of the Department of Translational Molecular Medicine at the ISNS Biennial meeting in Tokyo on October 11-13, 2018.